Skip to main content

Table 6 ROC results for CRMC, TA, and combination model

From: Additive value of texture analysis based on breast MRI for distinguishing between benign and malignant non-mass enhancement in premenopausal women

 

AUC

(95% CI)

Sensitivity (%)

Specificity (%)

p value

CRMC

83.7%

(0.76, 0.91)

80.6

72.5

< 0.01

TA

74%

(0.64, 0.84)

64.5

70

< 0.01

Combine

    

 Training set

88.7%

(0.83, 0.95)

82.3

80

< 0.01

 Validation set

81.9%

(0.68, 0.96)

77.8

72.2

< 0.01